Home / Tech News / Featured Tech News / Alan Wake studio, Remedy, is gearing up to reveal new IP at E3

Alan Wake studio, Remedy, is gearing up to reveal new IP at E3

Remedy is gearing up to reveal its latest project at this year’s E3, currently known simply as Project 7. Not much is currently known about what the Alan Wake studio has in store with P7, however it is believed to be Remedy’s first PlayStation release since 2003 as the upcoming title is expected to arrive on PS4 among other platforms.

Known for its Xbox console exclusives, Remedy is known for Alan Wake and Quantum Break, with its last releases for Sony’s PlayStation being 2001’s Max Payne and 2003’s Max Payne 2: The Fall of Max Payne for PS2.

The developer has since moved on from its partnership with Microsoft, ushering in 505 Games as its new publisher, bringing its experience from titles such as Sniper Elite III, Payday 2 and Brothers: A Tale of Two Sons to Project 7.

P7 was first spotted in an earnings report for Remedy, with a suggested launch window being 2019. Not much is known about Project 7 aside from it being a brand new title gracing PC, Xbox One and PlayStation 4, with more information coming as a part of 505 Games’ lineup, according to PCGamesN. It is, however, expected to retain the studio’s traditional cinematic storytelling approach, while incorporating online elements.

Of course, neither Remedy or 505 Games are commenting on the new title, so it seems we will find out more when E3 rolls around on June 12th.

KitGuru Says: Remedy seemed to hit the nail on the head with Alan Wake, whereas Quantum Break waned a little thanks to its poor PC port and the Universal Windows Platform limiting features commonly seen on the platform. Hopefully P7 takes after the studio’s former efforts. What would you like to see from the upcoming title?

Become a Patron!

Check Also

Triple-i initiative is coming back on April 10th for 45 minutes of ad-free game announcements and gameplay

The Triple-i Initiative is set to return on April 10th, 2025, at 9 a.m. PDT/6 …

We've noticed that you are using an ad blocker.

Thank you for visiting KitGuru. Our news and reviews teams work hard to bring you the latest stories and finest, in-depth analysis.

We want to be as informative as possible – and to help our readers make the best buying decisions. The mechanism we use to run our business and pay some of the best journalists in the world, is advertising.

If you want to support KitGuru, then please add www.kitguru.net to your ad blocking whitelist or disable your adblocking software. It really makes a difference and allows us to continue creating the kind of content you really want to read.

It is important you know that we don’t run pop ups, pop unders, audio ads, code tracking ads or anything else that would interfere with the KitGuru experience. Adblockers can actually block some of our free content, such as galleries!